Public Citizen Goes 0-2 In Recent Rx Safety Petitions
This article was originally published in The Pink Sheet Daily
Call for Amitiza black box warning rejected by FDA, which concluded that the current labeling for the constipation and irritable bowel syndrome drug does not need a warning regarding risk of abortion or the distribution of a Medication Guide or “Dear Doctor” letter; Public Citizen recently lost citizen petition bid to ban Aricept 23 mg tablets.
You may also be interested in...
Neither has announced a firm timeline, and the difference between Pfizer's 'October' and Moderna's 'November' could be mere hours or a few weeks, but Pfizer, by dint of luck or experience, is now in a position to offer the more optimistic projection on when it will seek an EUA. Both firms release their Phase III trial protocols, which seem in line with US FDA guidance.
Agency directs Sprout to disseminate corrective messages about the risks associated with the female sexual dysfunction pill. Sprout previously challenged FDA’s alcohol labeling requirements.
Under test payment model, Medicare would pay no more than most-favored-nation price for Part B and Part D drugs, but how and when the model program would be implemented remains unclear. BIO may pursue legal action as questions on how plan would be implemented and if the administration will provide notice and comment period for stakeholder input remain.